Whitcomb & Hess, Inc. Abb Vie Inc. Transaction History

Whitcomb & Hess, Inc.

$313 Million
Q3 2024

A detailed history of Whitcomb & Hess, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Whitcomb & Hess, Inc. holds 1,776 shares of ABBV stock, worth $311,474. This represents 0.11% of its overall portfolio holdings.

Number of Shares

1,776

Previous 1,837 3.32%

Holding current value

$311,474

Previous $315,000 11.11%

% of portfolio

0.11%

Previous 0.11%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 02, 2024	SELL	$163.84 - $199.33 $9,994 - $12,159	-61 Reduced 3.32%	1,776 $350,000
Q2 2024 Jul 11, 2024	SELL	$154.79 - $180.76 $9,751 - $11,387	-63 Reduced 3.32%	1,837 $315,000
Q1 2024 Apr 15, 2024	SELL	$159.82 - $182.1 $93,015 - $105,982	-582 Reduced 23.45%	1,900 $345,000
Q4 2023 Jan 17, 2024	BUY	$137.6 - $154.97 $19,126 - $21,540	139 Added 5.93%	2,482 $384,000
Q3 2023 Oct 18, 2023	BUY	$133.59 - $154.65 $935 - $1,082	7 Added 0.3%	2,343 $349,000
Q2 2023 Jul 07, 2023	BUY	$132.51 - $164.9 $927 - $1,154	7 Added 0.3%	2,336 $314,000
Q1 2023 Apr 19, 2023	BUY	$144.61 - $166.54 $56,253 - $64,784	389 Added 20.05%	2,329 $371,000
Q4 2022 Jan 20, 2023	BUY	$138.31 - $165.87 $12,862 - $15,425	93 Added 5.04%	1,940 $0
Q3 2022 Oct 21, 2022	SELL	$134.21 - $153.93 $1,610 - $1,847	-12 Reduced 0.65%	1,847 $248,000
Q2 2022 Aug 04, 2022	BUY	$137.62 - $174.96 $688 - $874	5 Added 0.27%	1,859 $285,000
Q1 2022 Apr 15, 2022	BUY	$131.98 - $163.75 $131 - $163	1 Added 0.05%	1,854 $300,000
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $199,067 - $251,878	1,853 New	1,853 $264,000

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Whitcomb & Hess, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Whitcomb & Hess, Inc. with notifications on news.

Account

Whitcomb & Hess, Inc. Abb Vie Inc. Transaction History